Hogg P - Search Results

1

Dual targeting of mitochondrial function and mTOR pathway as a therapeutic strategy for diffuse intrinsic pontine glioma.

Tsoli M, Liu J, Franshaw L, Shen H, Cheng C, Jung M, Joshi S, Ehteda A, Khan A, Montero-Carcabosso A, Dilda PJ, Hogg P, Ziegler DS. Tsoli M, et al. Among authors: hogg p. Oncotarget. 2018 Jan 8;9(7):7541-7556. doi: 10.18632/oncotarget.24045. eCollection 2018 Jan 26. Oncotarget. 2018. PMID: 29484131 Free PMC article.

2

A peptide trivalent arsenical inhibits tumor angiogenesis by perturbing mitochondrial function in angiogenic endothelial cells.

Don AS, Kisker O, Dilda P, Donoghue N, Zhao X, Decollogne S, Creighton B, Flynn E, Folkman J, Hogg PJ. Don AS, et al. Among authors: hogg pj. Cancer Cell. 2003 May;3(5):497-509. doi: 10.1016/s1535-6108(03)00109-0. Cancer Cell. 2003. PMID: 12781367 Free article.

3

Mechanism of selectivity of an angiogenesis inhibitor from screening a genome-wide set of Saccharomyces cerevisiae deletion strains.

Dilda PJ, Don AS, Tanabe KM, Higgins VJ, Allen JD, Dawes IW, Hogg PJ. Dilda PJ, et al. J Natl Cancer Inst. 2005 Oct 19;97(20):1539-47. doi: 10.1093/jnci/dji316. J Natl Cancer Inst. 2005. PMID: 16234568

4

Para to ortho repositioning of the arsenical moiety of the angiogenesis inhibitor 4-(N-(S-glutathionylacetyl)amino)phenylarsenoxide results in a markedly increased cellular accumulation and antiproliferative activity.

Dilda PJ, Decollogne S, Rossiter-Thornton M, Hogg PJ. Dilda PJ, et al. Cancer Res. 2005 Dec 15;65(24):11729-34. doi: 10.1158/0008-5472.CAN-05-2797. Cancer Res. 2005. PMID: 16357185

5

Arsenical-based cancer drugs.

Dilda PJ, Hogg PJ. Dilda PJ, et al. Cancer Treat Rev. 2007 Oct;33(6):542-64. doi: 10.1016/j.ctrv.2007.05.001. Epub 2007 Jul 10. Cancer Treat Rev. 2007. PMID: 17624680 Review.

6

Insight into the selectivity of arsenic trioxide for acute promyelocytic leukemia cells by characterizing Saccharomyces cerevisiae deletion strains that are sensitive or resistant to the metalloid.

Dilda PJ, Perrone GG, Philp A, Lock RB, Dawes IW, Hogg PJ. Dilda PJ, et al. Int J Biochem Cell Biol. 2008;40(5):1016-29. doi: 10.1016/j.biocel.2007.11.002. Epub 2007 Nov 13. Int J Biochem Cell Biol. 2008. PMID: 18160327

7

Metabolism of the tumor angiogenesis inhibitor 4-(N-(S-Glutathionylacetyl)amino)phenylarsonous acid.

Dilda PJ, Ramsay EE, Corti A, Pompella A, Hogg PJ. Dilda PJ, et al. J Biol Chem. 2008 Dec 19;283(51):35428-34. doi: 10.1074/jbc.M804470200. Epub 2008 Aug 23. J Biol Chem. 2008. PMID: 18723877 Free article.

8

Optimization of the antitumor efficacy of a synthetic mitochondrial toxin by increasing the residence time in the cytosol.

Dilda PJ, Decollogne S, Weerakoon L, Norris MD, Haber M, Allen JD, Hogg PJ. Dilda PJ, et al. J Med Chem. 2009 Oct 22;52(20):6209-16. doi: 10.1021/jm9008339. J Med Chem. 2009. PMID: 19788237

9

Selective targeting of mitochondria for the treatment of cancer.

Dilda PJ, Hogg PJ. Dilda PJ, et al. Discov Med. 2005 Feb;5(25):70-3. Discov Med. 2005. PMID: 20704927 Free article.

10

Noninvasive imaging of cell death using an Hsp90 ligand.

Park D, Don AS, Massamiri T, Karwa A, Warner B, MacDonald J, Hemenway C, Naik A, Kuan KT, Dilda PJ, Wong JW, Camphausen K, Chinen L, Dyszlewski M, Hogg PJ. Park D, et al. J Am Chem Soc. 2011 Mar 9;133(9):2832-5. doi: 10.1021/ja110226y. Epub 2011 Feb 15. J Am Chem Soc. 2011. PMID: 21322555 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

345 results

Search Page